UPDATE: Dr. Zelenko read our post and I got one of the details wrong. Here’s what he said:
“That’s not exactly right. My team treated 3,000 patients with oral hydroxychloroquine. I have now developed nebulized hydroxychloroquine with excellent results. 80 times faster response and improvement of symptoms. 1 hour with nebulized hydroxychloroquine vs 80 hours oral hydroxychloroquine.”
I had originally stated incorrectly that Dr. Zelenko treated 3,000 patients with nebulized hydroxychloroquine and have changed it below.
A Vladimir Zelenko, M.D., has just published a paper claiming a 99.3% survival rate among 3,000+ patients with “mild to moderate pulmonary symptoms” when given ‘hydroxychloroquine’ within the first 5 days of their symptoms:
Nebulized hydroxychloroquine as 150 mg HCQ in 6 mL (25 mg/mL) of isotonic sterile solution within the first five (5) days of COVID-19 symptoms (“Nebu HCQ”), has resulted in immediate improvement (<1 hour after use) in breathing in COVID-19 infected patients. Nebu HCQ served as a rescue medication with an 80x improvement in time and efficiency when compared to HCQ tablet (400-600 mg per day) combination therapy or Ivermectin combination therapy. No adverse events were reported outside of a bitter taste that quickly subsided.
The protocol used is as follows: 6 mL (25 mg HCQ per mL) per nebulizer session (15 minutes). Two sessions (6 mL total) in the first hour for patients with mild to moderate pulmonary symptoms from COVID-19.
Since March 2020, my team has successfully treated over 3,000 patients with Covid-19 with the Zelenko Protocol. Our high-risk patient survival rate was >99.3% (0.7% mortality) which represents a radical improvement when compared to national data of high-risk patients with a survival rate of 92.5% (7.5% mortality). I have provided counsel to governments, physicians and hospital networks regarding prophylaxis and prehospital care of Covid-19 and I am fully familiar with their results. Based on this real world experience and data, nebulized hydroxychloroquine significantly improves patient outcomes and should be considered as part of the armamentaria against Covid-19.
Nebulized means they breath the HCQ directly into their lungs, as opposed to taking it via a pill.
I’m sure this article will be blocked by our social media overlords, but we are just reporting apparent facts via Dr. Zelenko’s white paper. According to Zelenko, it really does work when administered soon after a patient shows symptoms.
You can read his full paper here.